Biopharmaceutical research and innovation is making strides in the world of mental health by expanding the understanding of the field and bringing about a new era of mental health medicine. No...
Read More

Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...
Read More

Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...
Read More

Today, one in five American adults and children experience a mental illness in any given year. As the prevalence of complex mental health conditions has grown, the cost of caring for patients has...
Read More

Each year, during the first full week of October, organizations across the country work to raise awareness for mental health disorders to educate the public, fight stigma and provide support....
Read More

Depression in the U.S. affects more than 6.5 million Americans age 65 and older. The Medicare Part D prescription drug benefit provides seniors and people living with disabilities access to...
Read More

Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers...
Read More

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...
Read More

Mental Illness Awareness Week, which takes place the first full week of October, is an opportunity to raise awareness of mental illness and make progress in eliminating stigmas that discourage...
Read More

According to the National Institute of Mental Health (NIMH), 1 in 4 American adults have been diagnosed with a mental health disorder, yet many know very little about the disease. However, the recent...
Read More